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Abstract
Objective—To assess depression in children with chronic kidney disease (CKD) and to 
determine associations with patient characteristics, intellectual and educational levels, and health 
related quality of life (HRQoL).
Study design—Subjects aged 6–17 years from the Chronic Kidney Disease in Children cohort 
study completed the Children’s Depression Inventory (CDI), Wechsler’s Abbreviated Scales of 
Intelligence, Wechsler Individual Achievement Test-II-Abbreviated, and the Pediatric Inventory of 
Quality of Life Core Scales 4.0. Regression analyses determined associations of CDI score and 
depression status with subject characteristics, intellectual and educational levels, and HRQoL. A 
joint linear mixed model and Weibull model were used to determine the effects of CDI score on 
longitudinal changes in glomerular filtration rate (GFR) and time to renal replacement therapy.
Results—344 subjects completed the CDI. Eighteen (5%) had elevated depressive symptoms and 
another 7 (2%) were being treated for depression. In adjusted analyses, maternal education beyond 
high school was associated with 5% lower CDI scores (estimate 0.95; 95% CI 0.92, 0.99). 
Depression status was associated with lower IQ (99 versus 88, P= 0.053), lower achievement (95 
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versus 77.5, P<0.05), and lower HRQoL by parent and child reports (effect estimates −15.48; 95% 
CI −28.71, −2.24 and −18.39; 95% CI −27.81, −8.96, respectively). CDI score was not related to 
change in GFR.
Conclusion—Children with depression had lower psychoeducational skills and worse HRQoL. 
Identifying and treating depression should be evaluated as a means to improve the academic 
performance and HRQoL of children with CKD.
Keywords
Child Depression Inventory; adolescents; children; mental health; quality of life; chronic renal 
insufficiency
Depression is a common co-morbidity in children with chronic medical disease1–5 and has 
been associated with poor adherence to medication and worse outcomes.4–6 Similar to 
children with other chronic diseases, children with chronic kidney disease (CKD) often have 
growth restriction, multiple surgical scars, and frequently miss school and other childhood 
activities. Compared with prior decades, children with CKD are experiencing improved 
survival but the adversities related to their underlying condition predispose them to the 
development of depression. Compared with a 12 month prevalence of depression of 7.5% in 
adolescents in the general population,7 prior studies assessing depression in pediatric 
CKD6,8–12 have found a point prevalence of 10–35%, with variations according to the 
specific populations studied (transplant versus dialysis versus pre-end stage renal disease 
and young children versus adolescents) and methods used to define depression.
Although studies investigating the role of depression in pediatric CKD are limited, the role 
of depression in adults with CKD is better defined. Studies in adults with CKD indicate that 
the prevalence of depression is between 20 and 40%.13–16 For adult hemodialysis patients, 
major depression is associated with a three-to-four fold greater risk of death,15 and those 
patients with CKD but not on dialysis have an increased risk of poor outcomes including 
hospitalizations, death and initiation of dialysis.16 In pediatrics, adverse effects of depression 
are suggested by studies in adolescents in which depression is associated with 
neurocognitive impairment that improves after remission of depression17 and in studies of 
children with chronic illness that show depression to be associated with poor quality of 
life.18,19 These findings may be relevant in pediatric chronic kidney disease because prior 
studies have found that 21–40% of children with CKD fall at least 1 SD below the mean on 
IQ and academic achievement21 and that children with CKD suffer from lower health related 
quality of life (HRQOL) than healthy children. 22
The Chronic Kidney Disease in Children (CKiD) cohort study is a prospective observational 
study of pediatric CKD patients with mild to moderate renal dysfunction from 54 pediatric 
nephrology centers throughout North America20. A primary goal of the study is to determine 
how a decline in kidney function affects neurocognitive function and behavior. Because prior 
studies evaluating depression in pediatric CKD are limited by small sample sizes (ranging 
from 15–60 subjects) and none have attempted to correlate depression with intellectual 
impairment, quality of life, or progression of disease we used Children’s Depression 
Inventory (CDI )23 data collected from the CKiD cohort to determine (1) the prevalence of 
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depression and elevated depressive symptoms in children with mild to moderate CKD; (2) 
the demographic and clinical factors associated with depression in pediatric CKD; (3) the 
relationship between depression and intellectual level, academic skills, and quality of life; 
and (4) the relationship between baseline depression and longitudinal changes in kidney 
function.
Methods
The CKiD study is a multicenter prospective, longitudinal, observational cohort study of 
children with mild-to-moderate CKD from 54 pediatric nephrology centers throughout 
North America.20 The CKiD study was initiated in 2005 and enrolled children, from a 
variety of pediatric nephrology practices, between the ages of 1–16 years with an estimated 
glomerular filtration rate (GFR) of 30–90 ml/min/1.73m2 (calculated by the original 
Schwartz equation24); exclusion criteria include prior malignancy, transplantation, or 
dialysis within the previous three months, and a limited number of other conditions. 
Children are seen initially at a baseline study visit and then again for a study visit 3–6 
months later at which point neurocognitive and psychosocial data are collected. Thereafter, 
subjects are followed longitudinally on an annual basis until they are 21 years of age, 
undergo transplantation, initiate dialysis or are transferred to an adult center. This report 
includes subjects enrolled from 2005–2008 between the ages of 6 and 17 years since these 
are the years of the study during which the CDI was administered and only children at least 
6 years of age completed the CDI. The CKiD study protocol was approved by the 
Institutional Review Boards of each participating center and informed consent was obtained 
from all participants. Further information regarding CKiD study design and objectives have 
been previously described.20
We performed a cross-sectional analysis of data collected at the baseline and 3–6 month 
study visit to determine the prevalence of depression and depressive symptoms and to 
determine the associations of depression with patient characteristics, intellectual function, 
overall academic skills, and quality of life. In a longitudinal analysis, we evaluated the 
relationship of CDI score to changes in GFR.
Depression
Participants completed the Children’s Depression Inventory (CDI) at the study visit that 
occurred 3–6 months after study entry. The CDI is a validated 27 question survey designed 
to assess depressive symptomatology and to offer information regarding likely diagnoses of 
depression in children 7–17 years of age.23 Children completed the CDI independently. For 
children who required help reading, the CDI was read to them by a study coordinator. The 
CDI assesses symptoms of depression in the domains of negative mood, interpersonal 
problems, ineffectiveness, anhedonia and negative self-esteem. The results from the CDI 
yield a raw score which is then converted into a T-score. The T-score is based on general 
population norms and standardized for age and sex, with a mean score and standard 
deviation of 50± 10 in the general child and adolescent population. A higher CDI T-score 
indicates the presence of more depressive symptoms; a CDI T-score ≥60 is considered to be 
high average and a T-score ≥65 is considered to be clinically significant. For this study, 
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status as depressed was assigned based on a CDI T-score ≥60 or on a self-reported prior 
diagnosis of depression currently being treated with an antidepressive medication. 
Depression was evaluated as a dichotomous outcome variable and depressive symptoms 
were evaluated as a continuous outcome variable measured by the CDI T-score.
Intellectual Functioning, Academic Achievement, and Quality of life measures
All intellectual, academic, and quality of life measures were obtained concurrently with the 
CDI at the 3–6 month CKiD study visit. Intelligence was measured by the Wechsler 
Abbreviated Scales of Intelligence (WASI).25 Academic achievement was measured by the 
Wechsler Individual Achievement Test-II-Abbreviated (WIAT-II-A)26 and the need for 
additional school support was assessed by self-reported presence of an Individualized 
Education Plan (IEP) or 504 plan in the school setting. HRQoL was evaluated by completion 
of the Pediatric Inventory of Quality of Life Core Scales (PedsQL) 4.0.27,28 The 
participants’ caregivers completed the PedsQL parent proxy form and the participants ≥ 8 
years completed the PedsQL child form.
Other Variables
Based on factors found to be associated with other neuropsychological measures in prior 
CKiD studies21,22,29 we also collected data regarding age, sex, race, maternal education, 
etiology of CKD, age at diagnosis, duration of CKD, GFR, urine protein:creatinine ratio, 
body mass index, height, casual blood pressure measurements, past history of psychiatric 
disease and current medication use as variables possibly related to depression. For the cross 
sectional analysis, demographic and medical history information was collected at the 
baseline study visit. For the longitudinal analysis, GFR was determined by plasma iohexol 
disappearance at the baseline visit, the first annual follow-up visit, and every two years 
thereafter.30 At intervening visits, GFR was estimated by validated equations.31 For this 
paper, GFR refers to estimated GFR or measured GFR when available.
Statistical Analyses
Univariate relationships between depression status and patient characteristics were computed 
using Wilcoxon rank-sum tests for continuous variables and chi-squared tests for categorical 
variables. To determine the relationships between CDI T-score and patient characteristics, 
we performed log-linear regression in a multi-variable model including variables found to be 
associated with depression in the univariate analysis or hypothesized a priori to be related to 
depression.
Intellectual assessment and HRQoL scores for subjects with and without depression were 
reported as median values with interquartile range (IQR) or frequencies and percentages. To 
determine the associations between depression and intellectual assessment and quality of 
life, we performed median regression analyses for continuous variables and logistic 
regression analyses for dichotomous variables. Median regression was used due to the 
HRQoL scales, which are bounded between 0 and 100 and are non-normally distributed. 
Each analysis controlled for height Z-score, maternal education, age, duration of CKD and 
incontinence (defined as not toilet trained or toilet trained with bed wetting) because these 
Kogon et al. Page 4
J Pediatr. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
have been previously reported as factors associated with neurocognitive measures and/or 
HRQoL in prior studies from the CKiD cohort. 21,22,32–33
In order to determine if baseline CDI score was associated with progression of CKD, we 
jointly modeled the effect of baseline CDI on longitudinal GFR and time to renal 
replacement therapy (RRT, defined as initiation of dialysis or kidney transplantation), using 
a linear mixed model for the longitudinal component and a Weibull model for the time to 
RRT. The joint model accounts for informative dropout, as subjects with lower GFRs and/or 
faster progression tend to receive RRT earlier.34 GFR was log-transformed for normality and 
CDI was centered at 45. No other covariates were included in this model.
All data analyses were carried out using SAS 9.2 (SAS Institute, Cary, NC) except the joint 
models, which were fit with the stjm package in Stata 12 (StataCorp, College Station, TX). P 
values <.05 were considered to be statistically significant.
Results
The CDI was completed by 344 children aged 6–17 years. Table I shows the clinical and 
demographic characteristics of the study subjects. The median age was 13 [IQR 10–15]. 
Most were male (59%), 61% were white and one-half had congenital disorders of the 
kidneys and urinary tract. Median GFR was 41.6 ml/min per 1.73m2 [IQR 31.9–53.6]. Seven 
percent of the children (25) carried a prior diagnosis of depression and 31% (107) had a 
prior history of any psychiatric illness. Of those with a prior diagnosis of depression, 8 were 
receiving anti-depressant medications at the time of the study visit.
Prevalence of Depressive Symptomatology
Twenty-five children (7%) met study criteria for depression; 17 had an elevated CDI score 
alone (T-score >60), 7 were taking an anti-depressant medication for treatment of depression 
and 1 had an elevated CDI score and was taking an anti-depressant. Of the 319 children 
without depression, 14 had a self-identified history of depression but were not taking an 
anti-depressant and had a normal CDI score. The median overall CDI score of the cohort 
was 43 [IQR 39–49]; for the subjects with depression, the median was 62 [IQR 56–67] and 
for the subjects without depression the median score was 42 [IQR 39–48]. Table I shows the 
clinical and demographic characteristics of the subjects according to depression status as 
defined by the study criteria. Subjects classified as depressed were more likely to have a 
mother with high school or less education, shorter stature, lower blood pressure, and a 
history of a prior psychiatric diagnosis.
Associated Demographic and Clinical Factors
In the multiple linear regression model examining the relationship between CDI score and 
patient characteristics, only maternal education was found to be significantly associated with 
CDI score (Table II). After adjusting for other demographic and disease-related factors, CDI 
scores among children whose mothers had more than a high school education were 5% 
(95%CI: 1%,8%) lower than those whose mothers had a high school education or less. The 
association of CDI T-score with BMI Z-score tended towards significance (effect estimate 
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1.02; 95% CI 1.00–1.04). Duration of CKD, congenital etiology of CKD, GFR and height 
and BP were not associated with CDI T-score.
Intellectual Level, Academic Skills, HRQoL
The Figure shows the unadjusted HRQoL parent and child report scores by depression 
status. Children with depression had median scores 15–35 points lower than the children 
without depression across all domains. The largest difference between children with and 
without depression was in social functioning. The lowest parent proxy HRQoL scores for 
subjects with and without depression were in school functioning (median 40 and 65, 
respectively) and the highest were in physical functioning (median 63 and 84, respectively). 
The lowest self-reported HRQoL scores for subjects with and without depression were in 
school functioning (median 59 and 65, respectively). The highest self-reported HRQoL 
score for subjects with depression was in physical functioning (median 67.5) and the highest 
in the subjects without depression was in social functioning (median 85).
Table III displays the the median HRQoL, intelligence and achievement scores and the 
results from the regression models for these scores after adjusting for maternal education, 
height Z-score, age, duration of CKD and urinary incontinence. Full scale IQ trended 
towards being lower in the subjects with depression than those without depression (median 
88 versus 99; p=0.053). The median achievement scores for the children with depression 
were in the borderline range and were lower than the median scores in the group without 
depression (77.5 in the group with depression versus 95 in the group without depression). 
Except for the parent proxy social HRQoL score, the associations of depression with parent 
proxy and self HRQoL scores overall and in all domains persisted after adjustment.
Longitudinal changes in GFR
Median follow-up time for this analysis was 4.22 years with a range of 0–7.51 years. In 
order to determine if CDI score was associated with decline in GFR, baseline CDI score and 
time to RRT were jointly modeled with GFR. Although there was a significant association 
between GFR and time to RRT (p<0.0001), baseline CDI score did not have any relationship 
with baseline GFR (β = −0.003, p=0.27), GFR trajectory over time (β = 0.0005, p=0.43), or 
progression to RRT (β = −0.0003, p=0.98).
Discussion
In this study evaluating depression in children with mild-to-moderate CKD, we identified a 
strong relationship between depression and HRQoL. We found that the presence of 
depressive symptoms was more strongly associated with HRQoL than with any other factor 
and that the magnitude of the relationship exceeded any other relationships found in other 
CKiD studies examining HRQoL.22,32,33 Prior CKiD studies evaluating factors associated 
with HRQoL have found associations within only certain domains of HRQoL or within a 
particular domain per child report but not the parent report. For example, Gerson et al found 
older age to be associated with overall HRQoL, physical HRQoL, emotional HRQoL and 
social HRQoL on the child measures but not at all in the parent proxy measures.22 In the 
current study, even after adjustment, a strong association between depression and HRQoL 
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was noted across all domains in the self-report measure and virtually all of the HRQoL 
domains in the parent proxy measure. The effect size of this relationship is also of a greater 
magnitude than that seen in prior studies. 22,32,33 In our study, the effect size seen was on the 
order of 15–20 points as opposed to the 1–5 point effect size seen in prior studies. Further 
demonstrating the importance of the relationship between depression and HRQoL, the 
quality of life items associated with depression were not limited to those related to mood but 
also included the mood-free items. These findings suggest that depression may represent a 
modifiable factor that influences all aspects of HRQoL in children with CKD and highlight 
the importance of assessing and addressing depression when evaluating and designing 
strategies to improve HRQoL. Studies of depression in other pediatric chronic disease have 
also found a unique and strong relationship between depression and HRQoL. A large study 
of pediatric epilepsy patients found that disease status, such as remission or complicated 
epilepsy, was not related to HRQoL, in contrast to the relationship that did exist between 
HRQoL and a history of an internalizing psychiatric disorder. 18 Likewise, a study of young 
adults with congenital heart disease found that even minor symptoms of depression had a 
larger impact on quality of life than exercise tolerance.19 Most closely related to our study, a 
Brazilian study evaluated the relationship between HRQoL and behavioral disorders in 135 
children with CKD stages 2–5 including transplant34 and found that none of the CKD 
related factors were associated with HRQoL, but that there was a significant negative 
correlation between the presence of behavioral and emotional disorders and HRQoL scores.
The relationship between depressive symptoms and IQ and overall academic skills was not 
as strong as that to HRQoL, although the median WIAT-II-A achievement score for children 
with depression was more than 1 standard deviation below the mean. From this it is unclear 
if lower IQ and achievement skills contribute to increased depressive symptoms or if 
depression causes impaired psychoeducational functions. Literature from the general 
adolescent population suggests that depression may lead to impairment of neurocognitive 
functioning.17 Knowing that children with CKD are at risk for intellectual impairment,21 it 
is important to determine the contribution of depression to this risk as we seek to improve 
school functioning and transition into productive adulthood.
The prevalence of depression in the CKiD cohort was lower than anticipated based on prior 
literature. Seven percent of children met study criteria for depression and 5% of the children 
demonstrated elevated depressive symptoms (T-score >60) as assessed by the CDI. This does 
not differ from the prevalence cited in the general adolescent population (7.5%)7 and is 
substantially less than that identified in other pediatric CKD studies in which up to 35% of 
subjects were reported to suffer from depression.6,8–12 One explanation for this unexpected 
finding may be that because CKiD is a large, rigorous, multicenter study requiring long term 
yearly follow-up, the children in this study come from a select group of patients with 
families that have the means to take the extra time to participate in the protracted time 
commitment of the study. Such a committed and organized family unit is likely protective 
against depression and may be the reason that depression was less prevalent in CKiD than in 
other smaller studies evaluating depression in CKD.
In the adjusted analysis, the only demographic or clinical factor determined to be associated 
with depressive symptoms was maternal education, with higher maternal education being 
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protective. Prior studies have likewise failed to find many demographic or clinical factors to 
be associated with depression in pediatric CKD. A study done in Peru assessing depressive 
symptoms in children on dialysis did not find an association between depressive symptoms 
and demographic factors.8 A study of pre-dialysis and dialysis pediatric CKD patients in 
Egypt also failed to find any associations with demographic or clinical factors.10 
Unfortunately, given their single center designs and small sample sizes, these findings may 
be reflective of inadequate power as opposed to a true lack of association and the possibility 
that there are other predictors of depression remains.
Our study of depression, although representing a larger sample of pediatric CKD patients 
than prior studies, is limited by the small number of children meeting criteria for depression 
which may, in part, be due to characteristics unique to study participants, as mentioned 
above. This reduces the power of our study to determine if there are specific clinical or 
demographic factors that relate depression to pediatric CKD. We are also limited in our 
ability to identify the true prevalence of depression due to the lack of a diagnostic interview, 
which is the gold standard to diagnose depression, and instead relied on the CDI and patient 
reported history. The utility of the CDI should not be discounted though because it has 
adequate sensitivity and specificity, 83% and 84% respectively.36 Using the CDI may have 
introduced some misclassification into this study, but as opposed to identifying spurious 
associations, this would have biased our results towards the null.
Given that previous HRQoL findings in children with CKD have not been consistent across 
parent and child measures or across all HRQoL domains22,32,33 depressive symptoms may 
be mediating the role that different factors have on HRQoL and should be considered as a 
potential modifying factor in future studies evaluating HRQoL. As we seek to develop new 
methods of reducing and eliminating the physical burdens of disease for our patients, we 
should simultaneously seek to eliminate the mental anguish and the diminished quality of 
life for them as well.
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Figure 1. 
Unadjusted HRQoL Overall and Domain Median Scores by Parent Proxy and Self Report
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Table 1
Descriptive statistics of the 344 children with CDI at 3–6 month visit stratified by depression status
Characteristic – Median [IQR] or N (%) Depressed (n=25) Non-Depressed (n=319) p-value
Age, years 14 [12, 16] 13 [10, 15] 0.15
Male sex 14 (56%) 188 (59%) 0.77
Race 0.68
 Caucasian 14 (56%) 195 (61%)
 Black 3 (12%) 54 (17%)
 Hispanic 5 (20%) 42 (13%)
 Other 3 (12%) 28 (9%)
Maternal Education 0.02
 High school or less 16 (64%) 126 (41%)
 More than high school 9 (36%) 184 (59%)
Etiology of CKD 0.15
Non-congenital 9 (36%) 163 (51%)
Congenital disorder of kidneys and urinary tract 16 (64%) 156 (49%)
Age at diagnosis of CKD, years 6.5 [0.0, 10.5] 2.5 [0.0, 8.5] 0.21
Duration of CKD, years 8.1 [3.8, 13.2] 8.3 [4.0, 11.9] 0.77
GFR, ml/min/1.73m2 44.4 [31.0, 53.0] 41.6 [32.0, 53.6] 0.90
Urine Protein/Creatinine 0.6 [0.2, 2.0] 0.5 [0.2, 1.2] 0.33
BMI percentile 52 [19, 94] 62 [34, 88] 0.73
Height z-score −1.3 [−1.9, −0.5] −0.8 [−1.4, 0.1] 0.03
Systolic BP z-score −0.2 [−0.8, 0.4] 0.3 [−0.5, 1.0] 0.03
Hypertension status 0.03
 No Hypertension 10 (42%) 120 (39%)
 Controlled Hypertension 12 (50%) 91 (29%)
 Uncontrolled Hypertension 2 (8%) 99 (32%)
Use of Anti-hypertensive Medication 20 (80%) 216 (68%) 0.20
History of psychiatric diagnosis
 ADD/ADHD 7 (28%) 34 (11%) 0.01
 Depression 11 (44%) 14 (5%) <0.001
 Learning disability 9 (36%) 40 (13%) 0.002
 Anxiety disorder 3 (12%) 13 (4%) 0.08
 Other 3 (14%) 18 (6%) 0.18
 Any of the above 18 (72%) 89 (28%) <0.001
Medication
 Immunosuppressive, Corticosteroid 3 (12%) 25 (8%) 0.46
 Antidepressants 8 (32%) 2 (1%) <0.001
 CNS stimulants 4 (16%) 14 (4%) 0.01
 Antipsychotics 0 (0%) 2 (1%) 0.69
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Characteristic – Median [IQR] or N (%) Depressed (n=25) Non-Depressed (n=319) p-value
 Sleep medications 0 (0%) 1 (<1%) 0.78
 Mood/behavior medication, other 0 (0%) 0 (0%) 1.00
 Any of the above 10 (40%) 41 (13%) <0.001
Patients with IEP and/or 504, % 13 (52%) 106 (33%) 0.06
Depressed subjects defined as CDI ≥ 60 or self-reported diagnosis of depression plus current antidepressive medication. P-values from Wilcoxon 
rank-sum test (continuous) or chi-squared test (categorical).
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Table 2
Multivariate Association of Covariates with CDI score
Covariate Estimate 95% CI p-value
Age, per year increase 1.00 (0.99, 1.00) 0.20
Male sex 1.01 (0.97, 1.05) 0.74
Maternal Education
 High school or less 1 (ref) -
 More than high school 0.95 (0.92, 0.99) 0.02
Duration of CKD 1.00 (0.99, 1.00) 0.74
Etiology of CKD
 Non-congenital 1 (ref) -
 Congenital disorder of kidneys and urinary tract 1.02 (0.98, 1.06) 0.32
GFR, ml/min/1.73m2 1.00 (0.98, 1.01) 0.65
Height z-score, per 1 unit increase 0.99 (0.97, 1.01) 0.42
BMI z-score, per 1 unit increase 1.02 (1.00, 1.04) 0.05
Hypertension status
 None 1 (ref) -
 Controlled 1.02 (0.98, 1.07) 0.31
 Uncontrolled 1.01 (0.97, 1.06) 0.58
Corticosteroid use 1.02 (0.94, 1.10) 0.63
CDI log-transformed for normality. Estimates and 95% CIs are exponentiated so that interpretation is multiplicative, i.e., 0.95 indicates a CDI score 
5% lower than reference.
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Table 3
PedsQL median scores and adjusted linear or logistic regression results for associations of depression status 
with intelligence, achievement, and quality of life measures
Outcome Depressed (n=25) Non-Depressed (n=319) Effect estimate (95% CI)
Unadjusted Adjusted
Full Scale IQ 88 [79, 97] 99 [86, 109]
−11.00* (−17.57, −4.43) −3.70 (−17.55, 10.16)
Achievement 77.5 [72, 97] 95 [83, 108]
−17.00* (−27.90, −6.10) −11.24 (−22.50, 0.03)
Child Overall HRQoL 57.5 [46, 72] 78 [67, 86]
−20.00** (−31.07, −8.93) −18.39** (−27.81, −8.96)
Child Physical HRQoL 67.5 [48.5, 78] 84 [72, 94]
−15.00** (−23.01, −6.99) −15.46* (−25.13, −5.79)
Child Emotional HRQoL 55 [40, 67.5] 75 [60, 90]
−20.00*** (−27.86, −12.14) −18.43*** (−27.31, −9.56)
Child Social HRQoL 60 [37.5, 80] 85 [70, 95] −20.00 (−43.47, 3.47) −14.23 (−32.53, 4.06)
Child School HRQoL 50 [30, 60] 65 [55, 75]
−15.00** (−23.17, −6.83) −15.00* (−25.53, −4.47)
Parent Overall HRQoL 54 [46, 72] 76 [63, 87]
−22.00*** (−32.37, −11.63) −15.48* (−28.71, −2.24)
Parent Physical HRQoL 63 [47, 81] 84 [66, 94]
−21.00* (−33.52, −8.48) −16.97* (−30.94, −3.00)
Parent Emotional HRQoL 55 [45, 75] 75 [60, 90]
−20.00*** (−29.70, −10.30) −17.76* (−31.77, −3.76)
Parent Social HRQoL 55 [40, 80] 80 [63, 95]
−25.00* (−42.45, −7.55) −19.66 (−40.36, 1.03)
Parent School HRQoL 40 [35, 55] 65 [50, 80]
−25.00*** (−31.87, −18.13) −21.35*** (−30.60, −12.11)
Odds ratio (95% CI)
IEP/504 Plan Usage 13 (52%) 106 (33%) 2.18 (0.96, 4.94) 1.78 (0.74, 4.30)
Median regression used for continuous variables, logistic used for IEP/504 Plan Usage. Adjusted Model controls for height z-score, maternal 
education, age, duration of CKD, and incontinence (defined as either day/night urine leakage or bedwetting after toilet training).
*p<0.05;
**p<0.001;
***p<0.0001
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Appendix
List of CKiD sites and principal investigators by clinical coordinating center
Sites Principal Investigator
Midwest Clinical Coordinating Center
Kansas City, MO
Bradley Warady, MD
Children’s Hospital of Winnipeg
Winnipeg, CA
Allison Dart, MD, MSc, FRCPC
Egleston Children’s Hospital, Emory University
Atlanta, GA
Larry Greenbaum, MD, PhD
Children’s Mercy Hospital
Kansas City, MO
Bradley Warady, MD
Cincinnati Children’s Hospital and Medical Center
Cincinnati, OH
Jens Goebel, MD, Mark Mitsnefes, MD
Seattle Children’s Hospital
Seattle, WA
Joseph Flynn, MD
University of New Mexico Children’s Hospital
Albuquerque, NM
Craig Wong, MD
Children’s Hospital of Alabama
Birmingham, AL
Sahar Fathallah, MD
University of California, Los Angeles
Los Angeles, CA
Isidro Salusky, MD; Ora Yadin, MD
Case Western Reserve University
Cleveland, OH
Katherine Dell, MD
Phoenix Children’s Hospital
Phoenix, AZ
Bruce Morgenstern, MD
British Columbia Children’s Hospital
Vancouver, WA
Tom Blydt-Hansen, MD, FRCPC
Medical College of Wisconsin
Milwaukee, WI
Cynthia Pan, MD
St. Louis Children’s Hospital
St. Louis, MO
Keefe Davis, MD
Oregon Health and Science University
Portland, OR
Amira Al-Uzri, MD; Randall Jenkins, MD
UCSF Children’s Hospital
San Francisco, CA
Anthony Portale, MD
University of Texas Southwestern Medical Center
Dallas, TX
Mouin Seikaly, MD
Oklahoma University Health Sciences Center
Oklahoma City, OK
Martin Turman, MD, PhD
Stanford University Medical Center
Standford, CA
Cynthia Wong, MD; Steven Alexander, MD
LeBonheur Children’s Medical Center
Memphis, TN
Colleen Hastings, MD
Northwest Pediatric Kidney Specialist
Portland, OR
Randall Jenkins, MD
Children’s Hospital of Boston
Boston, MA
Nancy Rodig, MD; William Harmon, MD
University of Wisconsin
Madison, WI
Sharon Bartosh, MD
University of California, San Diego
La Jolla, CA
Nadine Benador, MD; Robert Mak, MD, PhD
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Sites Principal Investigator
Cardinal Glennon Hospital
St. Louis, MO
Ellen Wood, MD
Children’s Kidney Specialists, Idaho
Boise, ID
Randall Jenkins, MD
Children’s Hospital of Los Angeles
Los Angeles, CA
Gary Lerner, MD
East Coast Clinical Coordinating Center
Philadelphia, PA
Susan Furth, MD, PhD
Children’s Hospital of Philadelphia
Philadelphia, PA
Susan Furth, MD, PhD
Carolinas Medical Center
Charlotte, NC
Susan Massengill, MD
East Carolina Universit
Greenville, NC
Guillermo Hidalgo, MD
Johns Hopkins Children’s Center
Baltimore, MD
Meredith Atkinson, MD
University of Michigan, Mott Hospital
Ann Arbor, MI
Debbie Gipson, MD
Texas Children’s Hospital, Baylor
Houston, TX
Poyyapakkam Srivaths, MD
University of Texas, Houston
Houston, TX
Joshua Samuels, MD
Children’s Hospital at Montefiore
Bronx, NY
Frederick Kaskel, MD, PhD
Children’s Hospital at Dartmouth
Dartmouth, NH
Debora Mattosian, MD
DeVos Children’s Hospital at Spectrum
Grand Rapids, MI
Yi Cai, MD
Riley Hospital for Children at Indiana Univ. Health
Indianapolis, IN
Sharon Andreoli, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY
Jeffrey Saland, MD
Nationwide Children’s Hospital, Ohio State Univ.
Columbus, OH
Amy Kogon, MD
University of Virginia
Charlottesville, VA
Victoria Norwood, MD
Hospital for Sick Children (Sick Kids)
Toronto, CA
Rulan Parekh, MD; Lisa Robinson, MD
University of Maryland
Baltimore, MD
Susan Mendley, MD
University of Rochester Medical Center, Golisano Children’s Hospital at Strong
Rochester, NY
Marc Lande, MD, George Schwartz, MD
University of Iowa
Iowa City, IO
Patrick Brophy, MD
University of Illinois, Chicago
Chicago, IL
Eunice John, MD
University of Florida
Gainesville, FL
Kiran Upadhyay, MD
University of North Carolina, Chapel Hill
Chapel Hill, NC
Maria Ferris, MD
Children’s Hospital of Michigan Tej Matoo, MD
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Sites Principal Investigator
Detroit, MI
Maimonides Medical Center
Brooklyn, NY
Juan Kupferman, MD
RBHS - Robert Wood Johnson Medical School
New Brunswick, NJ
Lynne Weiss, MD
Ann & Robert H. Lurie Children’s Hospital of Chicago
Chicago, IL
Craig Langman, MD
INOVA Fairfax Hospital for Children
Falls Church, VA
Patricia Seo-Mayer, MD
Children’s National Medical Center
Washington DC
Kanwal Kher, MD
Maria Fareri Children’s Hospital at Westchester
Valhalla, NY
Dmitry Samsonov, MD
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